Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody CetuximabKimio Yonesaka, Pasi A. Jänne, Federico Cappuzzo et al.|Science Translational Medicine|2011Cited by 670
Genome Sequencing of Rare Disease Patients Through the Korean Regional Rare Disease Diagnostic Support ProgramRin Khang, Chong Kun Cheon, Hane Lee et al.|Human Mutation|2025Cited by 2